Private Advisor Group, LLC I Bio, Inc. Transaction History

Private Advisor Group, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Oct 14, 2022	SELL	$0.23 - $160.0 $2,855 - $1.99 Million	-12,415 Reduced 40.67%	18,110 $3,000
Q2 2022 Jul 13, 2022	SELL	$0.23 - $0.46 $2,599 - $5,198	-11,300 Reduced 27.02%	30,525 $8,000
Q1 2022 May 12, 2022	BUY	$0.3 - $0.61 $3,149 - $6,404	10,499 Added 33.52%	41,825 $18,000
Q4 2021 Feb 10, 2022	BUY	$0.55 - $1.04 $8,113 - $15,341	14,751 Added 89.0%	31,326 $17,000
Q3 2021 Oct 14, 2021	SELL	$1.06 - $1.52 $848 - $1,216	-800 Reduced 4.6%	16,575 $18,000
Q2 2021 Aug 12, 2021	BUY	$1.22 - $1.65 $3,050 - $4,125	2,500 Added 16.81%	17,375 $26,000
Q1 2021 Apr 22, 2021	BUY	$1.18 - $2.62 $17,552 - $38,972	14,875 New	14,875 $23,000
Q3 2020 Nov 02, 2020	SELL	$1.7 - $6.41 $6,800 - $25,640	-4,000 Closed	0 $0
Q2 2020 Aug 17, 2020	BUY	$0.87 - $2.46 $3,480 - $9,840	4,000 New	4,000 $9,000

Ticker IBIO
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 9,006,580
Market Cap $24M
Description
iBio, Inc., a biotechnology company, provides contract development and manufacturing services to collaborators and third-party customers in the United States. The company operates in two segments: Biopharmaceuticals and Bioprocessing. Its lead therapeutic candidate is IBIO-100 that is being advanced for investigational new drug development for t...

Get notified when there are updates to the investment portfolio of Private Advisor Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Private Advisor Group, LLC with notifications on news.